Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Large Drop in Short Interest

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) was the target of a large decrease in short interest in October. As of October 30th, there was short interest totaling 112,756 shares, a decrease of 64.1% from the October 15th total of 313,781 shares. Based on an average daily volume of 907,649 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

Bayer Aktiengesellschaft Stock Up 0.6%

BAYRY stock traded up $0.09 during mid-day trading on Monday, hitting $15.75. 140,133 shares of the company were exchanged, compared to its average volume of 1,066,764. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.67 and a current ratio of 1.04. The firm has a market cap of $61.90 billion, a P/E ratio of -37.50, a P/E/G ratio of 1.96 and a beta of 0.56. The firm’s 50 day simple moving average is $13.66 and its 200 day simple moving average is $12.67. Bayer Aktiengesellschaft has a 1-year low of $7.65 and a 1-year high of $15.98.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.02). Bayer Aktiengesellschaft had a negative net margin of 3.12% and a positive return on equity of 16.10%. The company had revenue of $11.25 billion during the quarter, compared to analyst estimates of $11.21 billion. On average, sell-side analysts predict that Bayer Aktiengesellschaft will post 1.28 EPS for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

(Get Free Report)

Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture. Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day. Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers.

See Also

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.